Used in research to study the metabotropic glutamate receptor 2 (mGlu2), particularly as a positive allosteric modulator. Helps investigate neurological and psychiatric disorders such as schizophrenia, anxiety, and depression by enhancing receptor activity in brain circuits involved in mood and cognition. Valuable in preclinical studies for developing new therapeutic agents targeting glutamate signaling.